MoneyWorks4Me

The June 2022 quarter revenue stood at Rs. 931.97 millions, up 14.91% as compared to Rs. 811.01 millions during the corresponding quarter last year.A radical decline of -83.18% was reported in the net profit of the company for the quarter ended June 2022 to Rs. 17.56  millions from Rs. 104.43 millions.Operating profit for the quarter ended June 2022 decreased to 66.17 millions as compared to 153.90 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 931.97 811.01 14.91 931.97 811.01 14.91 3135.11 2474.50 26.70
Other Income -56.02 50.48 -210.97 -56.02 50.48 -210.97 158.41 171.80 -7.79
PBIDT 66.17 153.90 -57.00 66.17 153.90 -57.00 566.35 363.29 55.89
Interest 1.12 1.48 -24.32 1.12 1.48 -24.32 5.32 6.53 -18.53
PBDT 65.05 152.42 -57.32 65.05 152.42 -57.32 561.03 356.76 57.26
Depreciation 21.23 19.96 6.36 21.23 19.96 6.36 88.06 82.32 6.97
PBT 43.82 132.46 -66.92 43.82 132.46 -66.92 472.97 274.44 72.34
TAX 26.26 28.03 -6.31 26.26 28.03 -6.31 120.40 53.00 127.17
Deferred Tax -13.45 -4.78 181.38 -13.45 -4.78 181.38 -5.74 9.27 -161.92
PAT 17.56 104.43 -83.18 17.56 104.43 -83.18 352.57 221.44 59.22
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 7.10 18.98 -62.58 7.10 18.98 -62.58 18.06 14.68 23.05
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..